Microbiology 7- Evolution and emergence of new viruses Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Describe the evolution of viruses during human circulation

A

Within host evolution of HIV. The quasispecies that exists within a single infected person contains every single mutation at every single position in the genome.
The virus may encounter a bottleneck at transmission or during replication under limiting conditions
Drug or immune response that targets one site will lead to selection of beneficial mutations.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is meant by a quasispecies

A

progeny different to the others, each copy of the genome may contain errors, due to errors in reverse transcriptase.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe a bottleneck

A

Modest transmission, only few will be able to spread, but then diversity will accumulate,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the relative fitness of resistant strains

A

nd if such a mutation leads to a coding change in a target for a drug of antibody then that mutant virus will be fitter than its sister progeny under conditions where the drug is used.
Drug resistance thus occurs readily in the treated patient. The resistance mutation sometimes confers a fitness cost to the virus and this means the resistant virus is unlikely to spread beyond the treated patient. If there is no fitness cost then the drug resistant virus can predominate and render use of the drug redundant.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What features of viruses contributes to antiviral resistance

A

High mutation rate and large progeny numbers and short replication time make viral evolution in response to selective pressure very fast.
Relative fitness of drug resistant virus vs wild type virus in vivo can influence whether drug resistant viruses proliferate.
RNA viruses are particularly prone to generate many errors during their replication because their RNA dependent RNA polymerases lack proof reading activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the rationale for multi-drug therapy

A

Multiple HIV targets encoded by different regions of the genome, hence if resistant to one target it will not be resistant to another (error rate is 1 in 10^4 in a 10kb genome). Hence we need to have drugs against different targets, to reduce selection for resistant strains.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

As well as antiviral drugs, what else can be a selection pressure for viral evolution

A

Antibodies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe antigenic drift

A

During viral replication mutations can occur in the HA or NA, leading to changes in antigenic nature of these glycoproteins. This is termed antigenic drift. The resulting new strains are only partially attacked by our immune system, resulting in milder disease in adults who have previously acquired antibodies. Major histocompatibility changes usually result in altered codon reading frames and a nonviable virus.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe antigenic shift

A

With antigenic shift there is a complete change in NA, HA or both. This can only occur with influenza A because the mechanism involves the trading of RNA segments between animal and human strains. When 2 influenza types co-infect the same cell, undergo replication and capsid packaging, RNA segments can be mispackaged into another virus. The virus wields a new HA or GA glycoprotein that has never been exposed to the human immune system anywhere on the planet. So the entire human population would be susceptible, leading to devastating pandemics.
The new virus may displace any circulating viruses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Why do we need to update viruses every year

A

Vaccine updated every year to best represent the circulating strains- to account for antigenic shift and drift.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do new viruses emerge

A
Zoonosis
Genetic variation
Increased exposure- travel or world population
Increased exposure- spread of vector
New discoveries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why are we all susceptible to zoonosis

A

No previous exposure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe new viruses that have only been recently discovered or detected- but may have been there before

A

‘Non A non B’ hepatitis caused by hepatitis C virus
Human papillomaviruses 16 and 18 as cause of cervical cancer
HHV8 as cause of Kaposi’s Sarcoma noticed during the AIDS pandemic
Merkel cell polyoma virus identified in tumours as non human sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the global influences on emerging infections

A
Environmental modification; demographics
World population
Climate change
Travel
Farming practises; monocultures
Immunosuppressed humans
Medical progress
Spread of arboviruses due to climate change.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe arboviruses

A

Yellow fever; Dengue; West Nile; Zika; chikingunya;
Flaviviruses and alphaviruses; positive sense RNA genomes
Mosquito host
Global warming, decrease in mosquito control, imports, stagnant water in large cities, dams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the vector for the West Nile Virus

A

Culex tarsalis

17
Q

What type of hosts are humans for arboviruses

A

Deadend hosts- humans are not usually part of the life cycle.

18
Q

Describe the presence of the West Nile Virus in New York

A

West Nile Virus belongs to Japanese encephalitis group of flaviviruses
WNV discovered in 1937, but mild disease
1956 outbreak in Eastern Europe with symptoms of increased severity
1999 in New York 61 cases, 7 deaths all > 50 years of age
Concurrently, birds in Bronx Zoo and wild crows became ill
West Nile Virus is an arbovirus that was not seen before 1999 on the American continent. It is not know how the virus crossed from Asia to the Americas. The replication cycle involves infection of mosquitoes and birds are the natural host. The virus has spread across the USA in less than a decade.

19
Q

Discuss the potential origins of the West Nile Virus in New York

A

Subtractive differential analysis used to diagnose a human brain sample revealed WNV RNA
RT-PCR showed sequence identity with a virus circulating in Israel
Illegally imported bird?
Viraemic human?
Infected mosquito?

20
Q

Describe Dengue

A

3 billion people live in at risk areas
50-100 million cases of DF each year; 300 000 cases of DHF
DHF case fatality 5%
Mosquito- borne febrile disease
RNA virus
It is also called break-bone fever because of the severe and painful backache, muscle and joint pain.

21
Q

Describe the 4 main dengue serotypes

A

4 serotypes of DV cross reactivity but no cross protection- antibodies binding without providing protection is worse

Repeat infection of a second serotype, especially serotype 2 predisposes to a variant of disease called Dengue haemorrhagic fever, which causes haemorrhage or shock especially in children.

22
Q

What does the spread of Dengue Haemorrhagic fever correlate with

A

upsurge in mosquito population

23
Q

Describe the risk factors associated with Dengue Haemorrhagic fever

A
Virus strain
Pre-existing anti-dengue antibody
previous infection
maternal antibodies in infants
Age
Higher risk in secondary infections
Higher risk in locations with two or more serotypes circulating simultaneously at high levels (hyperendemic transmission)
24
Q

Why is antibody binding without protection dangerous

A

Fc binds to antigens, can be recognised by Fc receptors, virus taken into cells that it wouldn’t normally infect. It can enter macrophages, leading to cytokine storm, leads to leaky epithelial cells- haemorrhage.

25
Q

Describe Chikingunya

A

associated with prolonged arthralgia
Similar symptoms to dengue fever
But more chronic than dengue

26
Q

Describe the symptoms of the Zika Virus

A
Headache
Pale skin, rash
Fever
Red eyes
Diarrhoea
Muscle pain, arthralgia
27
Q

List the human viruses that have emerged from animals

A

Also Ebola, Hendra, Nipah which spill over but do not transmit efficiently

28
Q

Why was Nigeria successful in reducing the spread of Ebola

A

Nigeria’s success story by contact tracing and containment

29
Q

Describe Severe Acute Respiratory Syndrome SARS

A

Chain of human transmission began November 2002, Guandong province China.
Late February 2003 international spread.
July 2003 last chain of human transmission broken.
8422 cases in 29 countries, 916 total fatalities, 908 of them in China, Singapore, Canada, and Vietnam.
SARS coronavirus emerged in East Asia in 2003. The virus is normally found in bats. Farmed civet cats were an intermediate host in China for the evolution of a strain of the virus that could
attach to a receptor on human cells.

30
Q

Describe the transmission and clinical epidemiology of SARS

A

Infected respiratory droplets; concentrated virus sources on lift buttons and in bathroom drains.
Amplified by use of nebulizers in hospitals.
Children experienced mild disease, patients over 60 years have 55% mortality.
Patients most infectious at 10 days post infection, when also symptomatic.
Destruction of lung tissue from overexuberant immune response.
Emergency response coordinated, international, rapid.
Direct or indirect contact of mucous membranes (eyes, nose or mouth).

31
Q

Describe the characteristics of the SARS virus

A

Coronavirus; Large (30kb) positive sense RNA genome.
Envelope spike protein.
Receptor is human ACE-2 protein.
A virus almost identical isolated from masked palm civets and raccoon dogs in wet markets.
Chinese horseshoe bats harbour SARS-like coronaviruses that can use bat and human ACE2 as receptors.
S protein is highly plastic and can adapt to different receptors overcoming host range barriers.

32
Q

What is meant by a super-spreading event

A

Few people are responsible for more transmissions.

33
Q

Describe noroviruses

A

Noroviruses are small RNA viruses that cause diarrhoea and vomiting. There has been an increase in the incidence of norovirus disease in recent years. A new genotype of virus has emerged that appears to use a new receptor for host cell entry that is particularly widespread in humans.

34
Q

Describe MERS coronavirus

A

Health tourism and business travel spreading the virus beyond Midde East
Closely related to HKU4 and HKU5 two bat coronaviruses
High seropositivity rate in camels

ARDS in older infected person but can be asymptomatic in infected contacts.
Zoonosis from camels
Target DPP4 receptors on lungs

35
Q

What may be responsible for the next pandemic

A

MERS
Limited transmission

Diverse clinical signs

No vaccine, no antiviral

H7N9
Limited transmission

No vaccine but technology to make one is known

Antivirals but resistance tolerated.

36
Q

Can some strains cause multiple pandemics

A

Yes- unexposed population grows to adulthood- HI1N1

37
Q

Describe Man’s intervention as the cause of emerging viruses

A

Myxoma Virus released for rabbit control is Australia

Genetic manipulation creates a transmissible H5N1 influenza virus

38
Q

Define zoonosis and host range barrier

A

New viruses that infect humans often cross over from animal reservoirs. The crossing of an animal pathogen into humans is called zoonosis. This does not happen very often because there is a host range barrier. This means that most viruses that are adapted to infect animal hosts are compromised in their ability to replicate and spread in humans due to the genetic differences between host factors the virus needs. Because humans have no pre-existing immunity to animal viruses they can cause devastating outbreaks or pandemics.